Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate.

Willsky GR, Chi LH, Liang Y, Gaile DP, Hu Z, Crans DC.

Physiol Genomics. 2006 Aug 16;26(3):192-201. Epub 2006 May 9.

2.
4.

Improvement of impaired glucose tolerance by oral administration of vanadyl sulfate by gavage in streptozotocin-induced diabetic rats.

Tsunajima T, Tatsuki R, Satoh K, Yamamoto A, Hoshi K, Ichihara K.

Res Commun Mol Pathol Pharmacol. 1997 Nov;98(2):190-200.

PMID:
9467827
5.
6.

Influence of vanadium supplementation on oxidative stress factors in the muscle of STZ-diabetic rats.

Kurt O, Ozden TY, Ozsoy N, Tunali S, Can A, Akev N, Yanardag R.

Biometals. 2011 Oct;24(5):943-9. doi: 10.1007/s10534-011-9452-3. Epub 2011 Apr 10.

PMID:
21479831
7.

Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies.

Goldfine AB, Patti ME, Zuberi L, Goldstein BJ, LeBlanc R, Landaker EJ, Jiang ZY, Willsky GR, Kahn CR.

Metabolism. 2000 Mar;49(3):400-10.

PMID:
10726921
8.
9.

Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: effects on the oxidative and antioxidative systems.

Tas S, Sarandol E, Ayvalik SZ, Serdar Z, Dirican M.

Arch Med Res. 2007 Apr;38(3):276-83. Epub 2007 Jan 22.

PMID:
17350476
11.
12.

A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).

Xie M, Gao L, Li L, Liu W, Yan S.

J Inorg Biochem. 2005 Feb;99(2):546-51.

PMID:
15621288
13.

Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds.

Nakai M, Watanabe H, Fujiwara C, Kakegawa H, Satoh T, Takada J, Matsushita R, Sakurai H.

Biol Pharm Bull. 1995 May;18(5):719-25.

PMID:
7492989
14.

Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.

Bolkent S, Bolkent S, Yanardag R, Tunali S.

Diabetes Res Clin Pract. 2005 Nov;70(2):103-9. Epub 2005 Mar 5.

PMID:
16188572
15.

Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).

Willsky GR, Goldfine AB, Kostyniak PJ, McNeill JH, Yang LQ, Khan HR, Crans DC.

J Inorg Biochem. 2001 May;85(1):33-42.

PMID:
11377693
16.

Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.

Yao J, Battell ML, McNeill JH.

Can J Physiol Pharmacol. 1997 Feb;75(2):83-90.

PMID:
9114928
17.

Treatment of diabetes with vanadium salts: general overview and amelioration of nutritionally induced diabetes in the Psammomys obesus gerbil.

Shafrir E, Spielman S, Nachliel I, Khamaisi M, Bar-On H, Ziv E.

Diabetes Metab Res Rev. 2001 Jan-Feb;17(1):55-66. Review.

PMID:
11241892
18.

Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV).

Yuen VG, Orvig C, Thompson KH, McNeill JH.

Can J Physiol Pharmacol. 1993 Mar-Apr;71(3-4):270-6.

PMID:
8402391
19.

Administration of vanadyl sulfate by gavage does not normalize blood glucose levels in streptozotocin-induced diabetic rats.

Domingo JL, Sanchez DJ, Gomez M, Llobet JM, Corbella J.

Res Commun Chem Pathol Pharmacol. 1992 Mar;75(3):369-72.

PMID:
1509205
20.

Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats.

Li M, Smee JJ, Ding W, Crans DC.

J Inorg Biochem. 2009 Apr;103(4):585-9. doi: 10.1016/j.jinorgbio.2008.11.011. Epub 2008 Nov 28.

PMID:
19203797

Supplemental Content

Support Center